{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:15:59Z","timestamp":1793164559801,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/md.0000000000004459","type":"journal-article","created":{"date-parts":[[2016,10,5]],"date-time":"2016-10-05T11:39:08Z","timestamp":1475667548000},"page":"e4459","source":"Crossref","is-referenced-by-count":70,"title":["Complement activation and effect of eculizumab in scleroderma renal crisis"],"prefix":"10.1097","volume":"95","author":[{"given":"Arnaud","family":"Devresse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selda","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moglie","family":"Le Quintrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Demoulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Stordeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Gastoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Pirson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Morelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-78-20210309","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.3899\/jrheum.131210","article-title":"Scleroderma renal crisis","volume":"41","author":"Mouthon","year":"2014","journal-title":"J Rheumatol"},{"key":"R2-78-20210309","doi-asserted-by":"crossref","first-page":"iii32","DOI":"10.1093\/rheumatology\/ken483","article-title":"Renal complications and scleroderma renal crisis","volume":"48","author":"Denton","year":"2009","journal-title":"Rheumatology (Oxford"},{"key":"R3-78-20210309","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1182\/blood-2014-02-558296","article-title":"Dynamics of complement activation in aHUS and how to monitor eculizumab therapy","volume":"124","author":"Noris","year":"2014","journal-title":"Blood"},{"key":"R4-78-20210309","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R5-78-20210309","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ki.2015.253","article-title":"The emerging role of complement inhibitors in transplantation","volume":"88","author":"Fr\u00e9meaux-Bacchi","year":"2015","journal-title":"Kidney Int"},{"key":"R6-78-20210309","first-page":"2218","article-title":"Hypocomplementemia in systemic sclerosis \u2013 clinical and serological correlations","volume":"34","author":"Hudson","year":"2007","journal-title":"J Rheumatol"},{"key":"R7-78-20210309","first-page":"268","article-title":"Hypocomplementemia in systemic sclerosis","volume":"60","author":"Cuomo","year":"2008","journal-title":"Reumatismo"},{"key":"R8-78-20210309","doi-asserted-by":"crossref","first-page":"e0114856","DOI":"10.1371\/journal.pone.0114856","article-title":"The local complement activation on vascular bed of patients with systemic sclerosis: a hypothesis-generating study","volume":"10","author":"Scambi","year":"2015","journal-title":"PLoS One"},{"key":"R9-78-20210309","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"key":"R10-78-20210309","doi-asserted-by":"crossref","first-page":"3733","DOI":"10.1182\/blood-2013-12-547067","article-title":"Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP","volume":"123","author":"Cataland","year":"2014","journal-title":"Blood"},{"key":"R11-78-20210309","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-78-20210309","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R13-78-20210309","first-page":"39","article-title":"Complement activation in systemic sclerosis","volume":"31","author":"Wild","year":"1990","journal-title":"J Clin Lab Immunol"},{"key":"R14-78-20210309","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/ard.61.3.257","article-title":"Deficiency of complement-dependent prevention of immune precipitation in systemic sclerosis","volume":"61","author":"Arason","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R15-78-20210309","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12026-013-8422-y","article-title":"Complement and autoimmunity","volume":"56","author":"Ballanti","year":"2013","journal-title":"Immunol Res"},{"key":"R16-78-20210309","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2249.1991.tb02954.x","article-title":"Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection","volume":"86","author":"Feucht","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"R17-78-20210309","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/art.23662","article-title":"Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis","volume":"58","author":"Cohen","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R18-78-20210309","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1177\/0961203310368409","article-title":"Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases","volume":"19","author":"Shen","year":"2010","journal-title":"Lupus"},{"key":"R19-78-20210309","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/0961203307083279","article-title":"Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection","volume":"16","author":"Li","year":"2007","journal-title":"Lupus"},{"key":"R20-78-20210309","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.thromres.2007.11.005","article-title":"Regulated complement deposition on the surface of human endothelial cells: effect of tobacco smoke and shear stress","volume":"122","author":"Yin","year":"2008","journal-title":"Thromb Res"},{"key":"R21-78-20210309","first-page":"11","article-title":"Activation of the alternative complement pathway in systemic lupus erythematosus","volume":"26","author":"Wilson","year":"1976","journal-title":"Clin Exp Immunol"},{"key":"R22-78-20210309","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/ckj\/sfv101","article-title":"Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome","volume":"8","author":"Thomas","year":"2015","journal-title":"Clin Kidney J"},{"key":"R23-78-20210309","first-page":"1379","article-title":"Eculizumab in atypical hemolytic-uremic syndrome","volume":"369","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"R24-78-20210309","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.transproceed.2013.02.062","article-title":"Eculizumab for salvage treatment of refractory antibody-mediated rejection in kidney transplant patients: case reports","volume":"45","author":"Kocak","year":"2013","journal-title":"Transplant Proc"},{"key":"R25-78-20210309","first-page":"2286","article-title":"Eculizumab as rescue therapy in severe resistant lupus nephritis","volume":"54","author":"Pickering","year":"2015","journal-title":"Rheumatology (Oxford"},{"key":"R26-78-20210309","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.ajkd.2014.07.031","article-title":"Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab","volume":"65","author":"El-Husseini","year":"2015","journal-title":"Am J Kidney Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:30:33Z","timestamp":1620959433000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201607260-00078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":26,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004459","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}